Journal of Enzyme Inhibition and Medicinal Chemistry 2010-10-01

Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro.

Feray Kockar, Selma Sinan, Hatice Yildirim, Oktay Arslan

Index: J. Enzyme Inhib. Med. Chem. 25(5) , 715-9, (2010)

Full Text: HTML

Abstract

Serum paraoxonase (aryldialkylphosphatase, EC 3.1.8.1., PON1) is an esterase protein synthesised by the liver and released into the serum, where it is associated with HDL lipoproteins. In this study, we have determined the in vitro effects of the following antibiotics: sodium ampicillin, ciprofloxacin, Rifamycin SV and clindamiycin phosphate, on human hepatoma (HepG2) cells (liver hPON1). All the antibiotics caused a dose-dependent and time-dependent decrease in the paraoxonase activity while Rifamycin SV was the most effective antibiotic due to its low 50% inhibition concentration (IC(50)) value. Liver hPON1 activity was determined using paraoxon as a substrate. The IC(50) values of the drugs were calculated from graphs of hydratase activity (%) by plotting concentration of the drugs that showed an inhibition effect.


Related Compounds

Related Articles:

Fungal recognition enhances mannose receptor shedding through dectin-1 engagement.

2011-03-11

[J. Biol. Chem. 286(10) , 7822-9, (2011)]

Enantioseparation of chiral acids and bases on a clindamycin phosphate-modified zirconia monolith by capillary electrochromatography.

2012-08-17

[J. Chromatogr. A. 1251 , 244-8, (2012)]

Enantioseparation of basic chiral compounds on a clindamycin phosphate-silica/zirconia hybrid monolith by capillary electrochromatography.

2014-08-22

[J. Chromatogr. A. 1356 , 289-93, (2014)]

Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs.

1998-12-01

[Can. Vet. J. 39(12) , 753-6, (1998)]

In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.

2014-02-01

[J. Pharm. Sci. 103(2) , 567-79, (2014)]

More Articles...